Expanding research on the impact of financial hardship on emotional well-being: guidance of diverse stakeholders to the Emotional Well-Being and Economic Burden of Disease (EMOT-ECON) Research Network.

economic burden of disease emotional well-being financial toxicity medical financial hardship network

Journal

Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902

Informations de publication

Date de publication:
2023
Historique:
received: 29 03 2023
accepted: 11 07 2023
medline: 14 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

The Emotional Well-Being and Economic Burden (EMOT-ECON) Research Network is one of six research networks funded by the National Institutes of Health (NIH) to advance research about emotional well-being (EWB), and the only one that focuses on addressing how economic burden due to disease or illness affects EWB. The network convened researchers, patients, patient advocates, health care providers and other stakeholders from across the US to discuss the significance of addressing the impact of the economic burden of disease on EWB, the complexity of this prevalent problem for patients and families, and the research gaps that still need to be studied to ultimately develop strategies to reduce the impact of economic burden of disease on EWB and health. Participants identified some important future areas of research as those investigating: (i) prevalent and relevant emotions for patients experiencing economic burden of disease and financial hardship, and how their broader outlook on life is impacted; (ii) constructs and contexts that influence whether the economic burden is stressful; (iii) strategies to deal and cope and their positive or negative effects on EWB and health; and (iv) multi-level and multi-stakeholder interventions to address economic factors (e.g., costs, ability to pay), administrative burdens, education and training, and especially patients' emotional as well as financial status.

Identifiants

pubmed: 37575433
doi: 10.3389/fpsyg.2023.1196525
pmc: PMC10416236
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1196525

Subventions

Organisme : NCCIH NIH HHS
ID : U24 AT011310
Pays : United States

Informations de copyright

Copyright © 2023 Pisu, Liang, Pressman, Ryff, Patel, Hussein, Williams, Henrikson, Schoenberger, Pracht, Bradshaw, Carpenter, Matthis, Schwartz and Martin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancer Invest. 2020 Mar;38(3):139-142
pubmed: 32093505
JAMA. 2007 Oct 10;298(14):1685-7
pubmed: 17925521
Trials. 2022 May 13;23(1):402
pubmed: 35562781
Support Care Cancer. 2018 Mar;26(3):975-987
pubmed: 29022102
CA Cancer J Clin. 2022 Sep;72(5):437-453
pubmed: 35584404
J Pediatr Oncol Nurs. 2019 Jan/Feb;36(1):6-16
pubmed: 30798687
J Clin Oncol. 2020 Feb 1;38(4):292-301
pubmed: 31804869
Psychol Bull. 2005 Nov;131(6):925-971
pubmed: 16351329
Affect Sci. 2022 Nov 15;4(1):10-20
pubmed: 37070009
Support Care Cancer. 2022 Mar;30(3):2273-2282
pubmed: 34716793
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5995-9
pubmed: 22474371
J Cancer Surviv. 2019 Jun;13(3):406-417
pubmed: 31123985
Annu Rev Psychol. 2019 Jan 4;70:627-650
pubmed: 30260746
Psychol Bull. 2012 Jul;138(4):655-91
pubmed: 22506752
J Psychosoc Oncol. 2021;39(1):17-34
pubmed: 32876547
JCO Oncol Pract. 2021 Oct;17(10):e1413-e1423
pubmed: 34251880
Popul Health Manag. 2021 Dec;24(6):710-721
pubmed: 33989065
Int Rev Econ. 2017 Jun;64(2):159-178
pubmed: 29057014
Cancer. 2018 Nov 1;124(21):4181-4191
pubmed: 30475400
Nat Rev Immunol. 2011 Aug 05;11(9):625-32
pubmed: 21818124
J Natl Cancer Inst. 2016 Oct 20;109(2):
pubmed: 27754926
Oncologist. 2019 Aug;24(8):1121-1127
pubmed: 30877191
Oncology (Williston Park). 2013 Feb;27(2):80-1, 149
pubmed: 23530397
J Surg Oncol. 2019 Jul;120(1):85-92
pubmed: 30650186
Explor Res Clin Soc Pharm. 2022 Apr 14;6:100136
pubmed: 35909716
Trials. 2022 Oct 3;23(1):839
pubmed: 36192802
Community Ment Health J. 2020 May;56(4):606-613
pubmed: 31894440
J Gen Intern Med. 2019 Aug;34(8):1494-1502
pubmed: 31044413
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1202-1211
pubmed: 31061097
J Health Soc Behav. 2020 Mar;61(1):113-130
pubmed: 32009469

Auteurs

Maria Pisu (M)

Division of Preventive Medicine and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.

Margaret I Liang (MI)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Sarah D Pressman (SD)

Department of Psychological Science, University of California, Irvine, Irvine, CA, United States.

Carol D Ryff (CD)

Department of Psychology and Institute on Aging, University of Wisconsin-Madison, Madison, WI, United States.

Minal R Patel (MR)

Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, United States.

Mustafa Hussein (M)

Department of Health Policy and Management, Graduate School of Public Health, The City University of New York, New York, NY, United States.

Courtney P Williams (CP)

Division of Preventive Medicine and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.

Nora B Henrikson (NB)

Kaiser Permanente, Washington Health Research Institute, Seattle, WA, United States.

Yu-Mei Schoenberger (YM)

Division of Preventive Medicine and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, United States.

Laurel J Pracht (LJ)

Ovarian Cancer Research Alliance, New York, NY, United States.

Erin Bradshaw (E)

Patient Advocate Foundation, Patient Insight Institute, Hampton, VA, United States.

Terrell Terri Carpenter (TT)

Carpenter Primary Healthcare, Memphis, TN, United States.

Amy Matthis (A)

American Diabetes Association, Alexandria, VA, United States.

David L Schwartz (DL)

Departments of Radiation Oncology and Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.

Michelle Y Martin (MY)

Department of Preventive Medicine and Center for Innovation in Health Equity Research, University of Tennessee Health Science Center, Memphis, TN, United States.

Classifications MeSH